Skip to main content
OpenTrials

Clinical trial condition

Metastatic Solid Tumor

Explore clinical trials studying Metastatic Solid Tumor. Study availability and eligibility vary by location and protocol.

82 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Solid Tumor trial results

Completed

BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

NCT06253195

Conditions
Advanced Solid Tumor, Breast Cancer, Breast Diseases, +14 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun Yat Sen Memorial Hospital, Sun Yat Sen University (South) Guangzhou, Guangdong, China
  • Guangxi Medical University Cancer Hospital Nanning, Guangxi, China
View Trial Details
Completed

PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation

NCT05639751

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +6 more
Locations
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCLA Hematology/Oncology - Santa Monica Santa Monica, California, United States
  • Smilow Cancer Hospital Phase 1 Unit New Haven, Connecticut, United States
  • AdventHealth Medical Group Oncology Research at Celebration Celebration, Florida, United States
View all 32 locations
View Trial Details
Completed

A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

NCT04761198

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +5 more
Locations
  • Mereo Investigator Site Phoenix, Arizona, United States
  • Mereo Investigator Site Greenbrae, California, United States
  • Mereo Investigator Site Los Angeles, California, United States
  • Mereo Investigator Site Jacksonville, Florida, United States
View all 16 locations
View Trial Details
Completed

A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer

NCT04474470

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colorectal Adenocarcinoma, +14 more
Locations
  • California Cancer Associates for Research and Excellence Encinitas, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • UCSD Moores Cancer Center San Diego, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
View Trial Details

Related conditions